NAVLE Urinary

Canine Leptospirosis Study Guide

Leptospirosis is a globally important zoonotic bacterial disease caused by pathogenic spirochetes of the genus Leptospira.

Overview and Clinical Importance

Leptospirosis is a globally important zoonotic bacterial disease caused by pathogenic spirochetes of the genus Leptospira. This disease represents one of the most clinically significant infectious causes of acute kidney injury (AKI) in dogs and is a frequently tested topic on the NAVLE due to its clinical complexity, zoonotic potential, and importance in veterinary public health.

The 2023 ACVIM Consensus Statement updated recommendations to include leptospirosis vaccination as a core vaccine for all dogs, regardless of lifestyle, signaling the increased recognition of this disease's widespread occurrence even in urban and suburban environments.

High-YieldOn the NAVLE, leptospirosis should be your top differential for any dog presenting with acute kidney injury, especially if accompanied by hepatic involvement, fever, and thrombocytopenia. Remember: this disease is ZOONOTIC - always consider public health implications!
Serovar Primary Reservoir In Vaccine? Clinical Notes
Icterohaemorrhagiae Rats Yes Classic severe disease; hepatorenal
Canicola Dogs Yes Dogs are maintenance host
Grippotyphosa Raccoons, voles Yes Most common in US currently
Pomona Pigs, skunks, opossums Yes Livestock exposure risk
Bratislava Pigs, horses, rodents No (N. America) Emerging; in European vaccines

Etiology

The Organism

Leptospira species are thin, tightly coiled, motile spirochetes measuring 0.1 micrometers in diameter and 6-20 micrometers in length. Key morphological features include:

  • Gram-negative cell wall structure
  • Characteristic hook-shaped or question mark-shaped ends (hence the name 'interrogans')
  • Two periplasmic flagella enabling corkscrew motility
  • Best visualized by darkfield microscopy (too thin for routine light microscopy)
  • Obligate aerobe; grows optimally at 28-30 degrees Celsius

Clinically Important Serovars

NAVLE TipThe 4-serovar vaccine available in North America contains Icterohaemorrhagiae, Canicola, Grippotyphosa, and Pomona. Remember: immunity is serogroup-specific, so dogs can still be infected by non-vaccine serovars!
System Clinical Signs
Systemic Fever, lethargy, anorexia, vomiting, abdominal pain, weight loss
Renal (most common) Polyuria/polydipsia (early), oliguria/anuria (late), azotemia, renomegaly on palpation
Hepatic Icterus, hepatomegaly, elevated liver enzymes, hyperbilirubinemia
Hemorrhagic Petechiae, ecchymoses, epistaxis, melena, hematemesis, hematuria
Respiratory Cough, dyspnea, tachypnea (pulmonary hemorrhage syndrome - poor prognosis)
Musculoskeletal Muscle pain, stiffness, reluctance to move (myositis/vasculitis)
Ocular Uveitis, conjunctival hyperemia (less common in dogs than horses)

Transmission and Epidemiology

Routes of Infection

Leptospires enter the host through:

  • Intact mucous membranes (oral, nasal, conjunctival)
  • Skin wounds or abrasions
  • Waterlogged or macerated skin
  • Less commonly: bite wounds, venereal transmission, transplacental

Environmental Survival

  • Survives weeks to months in warm, moist soil
  • Thrives in stagnant or slow-moving water (ponds, puddles, streams)
  • Optimal conditions: warm temperature, neutral pH (6.9-7.4), high humidity
  • Killed by desiccation, UV light, and common disinfectants

Risk Factors

  • Exposure to standing water (ponds, puddles, flooded areas)
  • Contact with wildlife (raccoons, skunks, rats) or their urine
  • Periods following heavy rainfall or flooding
  • Urban/suburban environments with rodent populations
  • Boarding facilities (dog-to-dog transmission with serovar Canicola)
High-YieldLeptospirosis is NO LONGER just a 'rural dog' disease! Recent outbreaks have occurred in urban areas and boarding facilities. ALL dogs should be considered at risk regardless of lifestyle, breed, size, or age.
Test Sample Timing Advantages Limitations
MAT Serum Acute + convalescent (2-4 wks) Gold standard; serogroup identification Delayed results; vaccination interference
PCR Blood (early), Urine (later) Any time Rapid; unaffected by vaccination False negatives if on antibiotics
SNAP Lepto Serum Point-of-care Rapid (20 min); detects LipL32 Affected by vaccination
WITNESS Lepto Serum Point-of-care Rapid; IgM-based (earlier detection) Affected by vaccination

Pathophysiology

Disease Phases

Phase 1 - Leptospiremic Phase (Days 1-7): Following entry through mucous membranes or skin, leptospires rapidly disseminate via the bloodstream. Using their corkscrew motility, they efficiently penetrate tissue barriers by binding to vascular endothelial cadherin and disrupting endothelial cell junctions.

Phase 2 - Immune/Organ Phase (Day 7+): The host mounts an antibody response, clearing organisms from the blood. However, leptospires localize to target organs, particularly the kidneys and liver, causing tissue damage through:

  • Direct nephrotoxicity: LipL32 outer membrane protein binds TLR-2 on renal tubular epithelial cells, triggering inflammatory cascades (TNF-alpha, NF-kappa B activation)
  • Vasculitis: Endothelial damage leads to hemorrhage, edema, and impaired perfusion
  • Tubular dysfunction: Proximal tubule damage with Na-K ATPase inhibition and vasopressin resistance
  • Tubulointerstitial nephritis: Mixed inflammatory infiltrate with potential progression to fibrosis

Key Pathophysiological Concepts for NAVLE

  • Non-oliguric AKI is classic: Due to tubular dysfunction causing impaired concentrating ability before GFR decline
  • Hypokalemia common: Tubular potassium wasting precedes azotemia
  • Glucosuria with normoglycemia: Proximal tubular dysfunction impairs glucose reabsorption
  • Chronic renal carrier state: Organisms persist in renal tubules, shed intermittently in urine
Phase Drug Dose Notes
First Choice Doxycycline 5 mg/kg PO q12h x 14 days Clears renal tubular infection; eliminates carrier state
If vomiting Ampicillin 20-30 mg/kg IV q6-8h Until oral doxy tolerated; adjust for azotemia
Alternative Penicillin G 25,000-40,000 U/kg IV q6-8h Terminates leptospiremia but does not clear renal infection

Clinical Signs

Clinical presentation ranges from subclinical infection to severe multisystemic disease. The most common presentation in modern practice is acute kidney injury, often with concurrent hepatic involvement.

Clinical Presentations by Organ System

High-YieldThe CLASSIC NAVLE presentation is a young adult dog with acute onset lethargy, vomiting, azotemia, elevated liver enzymes, and thrombocytopenia. The combination of AKI + hepatopathy + thrombocytopenia should immediately trigger leptospirosis in your differential!

Diagnosis

Laboratory Abnormalities

Complete Blood Count (CBC)

  • Thrombocytopenia (14-73% of cases) - mild to moderate; not severe enough for spontaneous bleeding
  • Neutrophilia with left shift (27-94% of cases)
  • Non-regenerative anemia (18-92% of cases) - usually mild to moderate
  • Lymphopenia, monocytosis

Serum Biochemistry

  • Azotemia: Elevated BUN (54-100%) and creatinine (55-100%)
  • Hyperphosphatemia (42-100%)
  • Hepatic enzymes: Elevated ALP (19-94%), ALT (22-87%), AST (28-69%)
  • Hyperbilirubinemia (15-94%)
  • Electrolyte abnormalities: Hyponatremia, hypo- or hyperkalemia

Urinalysis

  • Isosthenuria (USG 1.008-1.012) - loss of concentrating ability
  • Glucosuria with normoglycemia (proximal tubular dysfunction)
  • Proteinuria
  • Bilirubinuria, granular casts, pyuria
NAVLE TipGLUCOSURIA + NORMOGLYCEMIA is a classic board question clue for proximal renal tubular dysfunction! When you see this combination with AKI, think leptospirosis (or other causes of Fanconi-like syndrome).

Specific Diagnostic Tests

MAT Interpretation

  • Unvaccinated dog: Single titer greater than or equal to 1:800 is suggestive
  • Vaccinated dog: Single titer greater than or equal to 1:1600 is suggestive
  • Definitive diagnosis: 4-fold rise in titer between acute and convalescent samples (2-4 weeks apart)
  • High confidence: Single titer greater than or equal to 1:6400

Diagnostic Imaging

Abdominal Ultrasound Findings

  • Renomegaly (60% of cases)
  • Increased renal cortical echogenicity (100% in some studies)
  • Medullary band of hyperechogenicity (may be specific for leptospirosis)
  • Reduced corticomedullary definition
  • Mild pyelectasia
  • Perirenal and peritoneal effusion
  • Hepatomegaly with hypoechoic parenchyma; gallbladder wall thickening

Thoracic Radiographs

  • Diffuse or caudodorsal interstitial to alveolar pattern
  • Reticulonodular pulmonary opacities (pulmonary hemorrhage)
  • Note: Pulmonary involvement indicates poor prognosis (survival drops to 40-50%)

Treatment

CRITICAL: Do NOT delay treatment pending diagnostic confirmation! Progression to irreversible AKI can occur within 24-48 hours.

Antibiotic Therapy

NAVLE TipDOXYCYCLINE is the ONLY antibiotic that reliably clears leptospires from renal tubules! Penicillins terminate leptospiremia but do not eliminate the carrier state. Always complete a FULL 2-WEEK COURSE of doxycycline.

Supportive Care

  • Fluid therapy: IV crystalloids to correct dehydration and support renal perfusion; CAREFUL monitoring - overhydration risk is HIGH in oliguric patients
  • Antiemetics: Maropitant (Cerenia), ondansetron
  • Gastroprotection: H2 blockers, proton pump inhibitors, sucralfate
  • Nutritional support: Enteral feeding (NG/E-tube) if prolonged anorexia
  • Urine output monitoring: Closed collection system or frequent body weight measurement
  • Hemodialysis: Consider early referral for oliguric/anuric patients or progressive azotemia despite appropriate therapy

Prognosis

  • Overall survival: Approximately 80% with prompt, aggressive treatment
  • With hemodialysis: Greater than 80% survival in otherwise fatal oliguric/anuric AKI
  • Pulmonary hemorrhage syndrome: Survival drops to 40-50%
  • Chronic sequelae: 33-40% of survivors may have residual chronic kidney disease
  • Without dialysis (anuric): Prognosis is grave

Prevention

Vaccination

Per the 2023 ACVIM Consensus Statement, leptospirosis vaccination is now recommended as a CORE vaccine for ALL dogs, regardless of lifestyle, breed, size, or geographic location.

Vaccine Protocol

  • Initial series: 2 doses, 3-4 weeks apart, starting at 12 weeks of age
  • Boosters: Annual revaccination required (bacterin vaccines)
  • Duration of immunity: At least 12 months (some studies show 15 months)
  • Serovars covered (N. America): Icterohaemorrhagiae, Canicola, Grippotyphosa, Pomona

Vaccine Safety

  • Modern vaccines have improved safety profiles
  • Adverse event rates similar to other common vaccines (less than 53 events per 10,000 doses)
  • Historical concerns about small breed reactions have been addressed with newer formulations

Zoonotic Considerations

Leptospirosis is the most common zoonotic disease worldwide! Veterinary staff and pet owners are at risk.

Client Education

  • Avoid direct contact with urine
  • Wear gloves when cleaning urine accidents
  • Disinfect contaminated areas with iodine-based products or dilute bleach
  • Wash hands thoroughly after handling infected pets
  • Immunocompromised family members should consult their physician
  • Encourage dog to urinate away from standing water and common areas

Memory Aids

LEPTO-AKI Mnemonic:

  • Liver involvement (elevated ALP, ALT, bilirubin)
  • Elevated BUN and creatinine (azotemia)
  • Platelets low (thrombocytopenia)
  • Tubular damage (glucosuria, isosthenuria)
  • O-utbreak potential (ZOONOTIC!)

Treatment Memory Aid - 'DOXY Does it All':

  • Doxycycline is first choice
  • Oral route preferred
  • X-terminates renal carriage (only abx that does!)
  • Y = 2 weeks (14 days minimum)

Practice NAVLE Questions

Test your knowledge with 10,000+ exam-style questions, detailed explanations, and timed exams.

Start Your Free Trial →